Fate Therapeutics, Inc. Competitors

FATE 
$1.7889
*  
0.0711
3.82%
Get FATE Alerts
*Delayed - data as of May 3, 2016 12:56 ET  -  Find a broker to begin trading FATE now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    FATE Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Competitor Industry: Biotechnology: Biological Products (No Diagnostic Substances)

Fate Therapeutics, Inc.

CompanyName
Symbol: Market
LastSale NetChange Volume Today's High / Low ▼ 52 Weeks High / Low P / E Ratio Market Cap
Biogen Inc.
BIIB: NASDAQ-GS
$ 275.165 1.48 ▲ 842,796 $ 276.14
$ 271.09
$ 420.99
$ 242.07
16.9 60,171,156
Amgen Inc.
AMGN: NASDAQ-GS
$ 156.56 -2.43 ▼ 1,287,382 $ 158.4599
$ 156
$ 181.81
$ 130.09
16.55 117,747,367
China Biologic Products, Inc.
CBPO: NASDAQ-GS
$ 117.23 -3.20 ▼ 156,998 $ 120.47
$ 116.31
$ 144.2899
$ 80.60
35.85 3,117,263
Bio-Techne Corp
TECH: NASDAQ-GS
$ 101.85 8.55 ▲ 412,126 $ 103.86
$ 95.01
$ 114.56
$ 79.95
38.29 3,787,903
Gilead Sciences, Inc.
GILD: NASDAQ-GS
$ 87.7601 -1.24 ▼ 5,429,545 $ 89.12
$ 87
$ 123.37
$ 81.89
7.51 119,954,542
Kite Pharma, Inc.
KITE: NASDAQ-GS
$ 45.945 -1.86 ▼ 237,434 $ 47.55
$ 45.78
$ 89.84
$ 38.41
NE 2,243,954
Neurocrine Biosciences, Inc.
NBIX: NASDAQ-GS
$ 45.46 -1.25 ▼ 310,795 $ 47.22
$ 44.81
$ 58.46
$ 31.25
NE 3,930,153
bluebird bio, Inc.
BLUE: NASDAQ-GS
$ 44.1996 -1.67 ▼ 348,208 $ 45.6899
$ 43.86
$ 197.35
$ 37.40
NE 1,632,203
Juno Therapeutics, Inc.
JUNO: NASDAQ-GS
$ 40.50 -1.79 ▼ 391,322 $ 42.26
$ 40.0701
$ 69.28
$ 22.37
NE 4,214,430
Spark Therapeutics, Inc.
ONCE: NASDAQ-GS
$ 36.12 -1.50 ▼ 135,212 $ 37.37
$ 36.01
$ 76.24
$ 21.20
NE 977,552
Seattle Genetics, Inc.
SGEN: NASDAQ-GS
$ 35.33 -1.04 ▼ 361,738 $ 36.28
$ 34.965
$ 52.3299
$ 26.02
NE 4,943,833
DBV Technologies S.A.
DBVT: NASDAQ-GS
$ 33.79 0.02 ▲ 47,940 $ 33.91
$ 33.56
$ 44.759
$ 22.5475
NE 1,635,774
Editas Medicine, Inc.
EDIT: NASDAQ-GS
$ 32.64 -0.87 ▼ 21,927 $ 33.5199
$ 32.635
$ 43.99
$ 12.57
NE 1,194,787
Heska Corporation
HSKA: NASDAQ-CM
$ 35.85 6.06 ▲ 221,983 $ 36.95
$ 31
$ 40.29
$ 23.22
48.45 237,901
Acceleron Pharma Inc.
XLRN: NASDAQ-GM
$ 28.90 -1.43 ▼ 217,078 $ 30.35
$ 28.75
$ 50.86
$ 20
NE 1,072,074
Cellectis S.A.
CLLS: NASDAQ-GM
$ 27.12 -0.54 ▼ 60,370 $ 27.71
$ 27
$ 50
$ 18
NE 954,054
Repligen Corporation
RGEN: NASDAQ-GS
$ 27.25 -0.13 ▼ 47,399 $ 27.41
$ 26.74
$ 42.48
$ 20.07
93.97 900,122
Acorda Therapeutics, Inc.
ACOR: NASDAQ-GS
$ 25.99 -1.20 ▼ 166,510 $ 27.06
$ 25.95
$ 43.63
$ 24.83
83.84 1,189,017
AveXis, Inc.
AVXS: NASDAQ-GS
$ 24 -0.38 ▼ 23,889 $ 24.50
$ 23.25
$ 29.63
$ 16.11
NE 551,952
Qiagen N.V.
QGEN: NASDAQ-GS
$ 22.33 -0.19 ▼ 378,276 $ 22.40
$ 22.145
$ 28.53
$ 20.10
43.78 5,203,984
Eiger BioPharmaceuticals, Inc.
EIGR: NASDAQ-GM
$ 19.6858 -0.71 ▼ 7,606 $ 20.06
$ 19.55
$ 40.054
$ 12.9013
NE 138,155
Coherus BioSciences, Inc.
CHRS: NASDAQ-GM
$ 19.25 -0.72 ▼ 63,700 $ 19.80
$ 18.96
$ 38.10
$ 12.04
NE 752,733
La Jolla Pharmaceutical Company
LJPC: NASDAQ-CM
$ 18.38 -0.58 ▼ 36,230 $ 18.8532
$ 18.21
$ 44.9899
$ 12.68
NE 335,509
Atara Biotherapeutics, Inc.
ATRA: NASDAQ-GS
$ 16.87 -1.07 ▼ 90,163 $ 17.94
$ 16.77
$ 65.5599
$ 13.31
NE 483,005
NanoString Technologies, Inc.
NSTG: NASDAQ-GM
$ 16.38 -0.08 ▼ 56,829 $ 16.50
$ 16.035
$ 19.81
$ 11.08
NE 319,525